OneSource Specialty Pharma (NSE:ONESOURCE) PEG Ratio: N/A (As of Aug. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONESOURCE OneSource Specialty Pharma Ltd NSE:ONESOURCE
8 GF Score
Price ₹1,483.60
! 3 Warning Signs
View Full Analysis

What is OneSource Specialty Pharma PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, OneSource Specialty Pharma's PE Ratio without NRI is 0.00. OneSource Specialty Pharma's 5-Year EBITDA growth rate is 0.00%. Therefore, OneSource Specialty Pharma's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for OneSource Specialty Pharma's PEG Ratio or its related term are showing as below:



NSE:ONESOURCE's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.725
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


OneSource Specialty Pharma  (NSE:ONESOURCE) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


OneSource Specialty Pharma PEG Ratio Related Terms


OneSource Specialty Pharma PEG Ratio Historical Data

* Premium members only.

The historical data trend for OneSource Specialty Pharma's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OneSource Specialty Pharma PEG Ratio Chart

OneSource Specialty Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
PEG Ratio
0.00 0.00 0.00 0.00

OneSource Specialty Pharma Quarterly Data
Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

NSE:ONESOURCE vs VRTX, REGN, RVMD: PEG Ratio Comparison

For the Biotechnology subindustry, OneSource Specialty Pharma's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OneSource Specialty Pharma PEG Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OneSource Specialty Pharma's PEG Ratio distribution charts can be found below:

* The bar in red indicates where OneSource Specialty Pharma's PEG Ratio falls into.


NSE:ONESOURCE
8GF Score
OneSource Specialty Pharma Ltd NSE:ONESOURCE
PEG Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OneSource Specialty Pharma PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

OneSource Specialty Pharma's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


OneSource Specialty Pharma Business Description

Other Exchanges 544292:India
Address Bannerghatta Road, Star 1, Opp IIM Bangalore, Bilekahalli, Bangalore, KA, IND, 560076
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score

Get the complete analysis for NSE:ONESOURCE

PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,483.60
Price